Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Marwa El-Hussieny, Mansoura A. Abd-El-Maksoud, Fouad M. Soliman, Marwa A. Fouad & Mohamed K. El-Ashrey. (2023) Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Cesare Mancuso, Raffaella Siciliano, Eugenio Barone, David Allan Butterfield & Paolo Preziosi. (2011) Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. Expert Opinion on Investigational Drugs 20:9, pages 1243-1261.
Read now
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
Sandra A Jacobson & Marwan N Sabbagh. (2008) Donepezil: potential neuroprotective and disease-modifying effects. Expert Opinion on Drug Metabolism & Toxicology 4:10, pages 1363-1369.
Read now
Read now
Articles from other publishers (26)
Linyan Duan, Xingfan Li, Rong Ji, Zhizhong Hao, Mingyue Kong, Xuejun Wen, Fangxia Guan & Shanshan Ma. (2023) Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases. Polymers 15:9, pages 2196.
Crossref
Crossref
Rouan Pan. (2023) Current drug treatments in Alzheimer’s disease. Highlights in Science, Engineering and Technology 36, pages 1492-1498.
Crossref
Crossref
Ishtiaque Ahammad, Zeshan Mahmud Chowdhury, Arittra Bhattacharjee, Sheikh Sunzid Ahmed, Farzana Akter, Mohammad Uzzal Hossain, Keshob Chandra Das, Chaman Ara Keya & Md. Salimullah. (2023) Structure-based pharmacological screening, molecular docking and dynamic simulation reveals Dexketoprofen as a repurposable drug against Alzheimer's disease. Informatics in Medicine Unlocked 43, pages 101380.
Crossref
Crossref
Sarvin Sanaie, Saba Nikanfar, Zahra Yousefi Kalekhane, Akbar Azizi-Zeinalhajlou, Saeed Sadigh-Eteghad, Mostafa Araj-Khodaei, Mohammad Hossein Ayati & Sasan Andalib. (2022) Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights. Metabolic Brain Disease 38:1, pages 137-162.
Crossref
Crossref
Thankhoe A. Rants’o, Divan G. van Greunen, C. Johan van der Westhuizen, Darren L. Riley, Jenny-Lee Panayides, Lizette L. Koekemoer & Robyn L. van Zyl. (2022) The in silico and in vitro analysis of donepezil derivatives for Anopheles acetylcholinesterase inhibition. PLOS ONE 17:11, pages e0277363.
Crossref
Crossref
Pengli Guo, Mengnan Zeng, Bing Cao, Meng Liu, Yuhan Zhang, Jufang Jia, Qinqin Zhang, Beibei Zhang, Ru Wang, Weizheng Xiong, Xiaoke Zheng & Weisheng Feng. (2022) Camellia oil improves Aβ25-35-induced memory impairment by regulating the composition of the gut microbiota and lipid metabolism in mice. Journal of Functional Foods 96, pages 105214.
Crossref
Crossref
Pengli Guo, Mengnan Zeng, Shengchao Wang, Bing Cao, Meng Liu, Yuhan Zhang, Jufang Jia, Qinqin Zhang, Beibei Zhang, Ru Wang, Xiaoke Zheng & Weisheng Feng. (2022) Eriodictyol and Homoeriodictyol Improve Memory Impairment in Aβ25–35-Induced Mice by Inhibiting the NLRP3 Inflammasome. Molecules 27:8, pages 2488.
Crossref
Crossref
Samuel L. Warren & Ahmed A. Moustafa. 2022. Alzheimer's Disease. Alzheimer's Disease
217
232
.
Francesca Persano, Svetlana Batasheva, Gölnur Fakhrullina, Giuseppe Gigli, Stefano Leporatti & Rawil Fakhrullin. (2021) Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders. Journal of Materials Chemistry B 9:12, pages 2756-2784.
Crossref
Crossref
Mehrnoosh Nikpour, Ali Sharafi, Mehrdad Hamidi & Sina Andalib. (2020) Effect of Colloidal Aqueous Solution of Fullerene (C60) in the Presence of a P-Glycoprotein Inhibitor (Verapamil) on Spatial Memory and Hippocampal Expression of Sirtuin6, SELADIN1, and AQP1 Genes in a Rat Model of Alzheimer’s Disease. ACS Chemical Neuroscience 11:17, pages 2549-2565.
Crossref
Crossref
Shengwei Liu, Cui He, Yuan Liao, Hailin Liu, Wanli Mao & Zhengze Shen. (2020) Enhancing and Complementary Mechanisms of Synergistic Action of Acori Tatarinowii Rhizoma and Codonopsis Radix for Alzheimer’s Disease Based on Systems Pharmacology. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-26.
Crossref
Crossref
Jing Jiang, Gang Liu, Suhua Shi, Yujie Li & Zhigang Li. (2019) Effects of manual acupuncture combined with donepezil in a mouse model of Alzheimer’s disease. Acupuncture in Medicine 37:1, pages 64-71.
Crossref
Crossref
Yuan Dong, Xiaoheng Li, Jinbo Cheng & Lin Hou. (2019) Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?. International Journal of Molecular Sciences 20:3, pages 558.
Crossref
Crossref
Meng-Ni Wu, Yi-Hui Kao, Ping-Song Chou, Tzu-Chao Lin, Lin-Li Kao & Yuan-Han Yang. (2018) Location of white matter changes and response to donepezil in patients with Alzheimer's disease: A retrospective and observational study. Geriatrics & Gerontology International 18:1, pages 123-129.
Crossref
Crossref
Ruby E. Evande, Rinku Dutta, Chalet Tan, Jean L. Grem & Ram I. Mahato. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology
959
970
.
Christophe Genicot & Laurent Provins. 2016. Lead Generation. Lead Generation
513
546
.
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
215
225
.
Zhijie Li, Qing Tong, Huifang Xu, Li Hu, Rong Zhao, Fang Zhou, Wei Pan & Li Zhou. (2015)
Therapeutic Effects of TianDiJingWan on the A
β
25–35
-Induced Alzheimer’s Disease Model Rats
. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-9.
Crossref
Crossref
Mengyuan Liu, Ying Zhang, Ya Ruth Huo, Shuling Liu, Shuai Liu, Junwei Wang, Change Wang, Jinhuan Wang & Yong Ji. (2014) Influence of the rs1080985 Single Nucleotide Polymorphism of the CYP2D6 Gene and APOE Polymorphism on the Response to Donepezil Treatment in Patients with Alzheimer's Disease in China. Dementia and Geriatric Cognitive Disorders Extra 4:3, pages 450-456.
Crossref
Crossref
Yang Su, Qiuhong Wang, Changfu Wang, Kelvin Chan, Yanping Sun & Haixue Kuang. (2014) The treatment of Alzheimer's disease using Chinese Medicinal Plants: From disease models to potential clinical applications. Journal of Ethnopharmacology 152:3, pages 403-423.
Crossref
Crossref
Rüdiger Hardeland. (2011) Cognitive Enhancers in Moderate to Severe Alzheimer's Disease. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6344.
Crossref
Crossref
Andreas Kern & Christian Behl. (2009) The unsolved relationship of brain aging and late-onset Alzheimer disease. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:10, pages 1124-1132.
Crossref
Crossref
Marco Calabria, Cristina Geroldi, Giulia Lussignoli, Federica Sabbatini & Orazio Zanetti. (2009) Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in Alzheimer's disease: A 21-month follow-up “real world” study. Archives of Gerontology and Geriatrics 49:1, pages e6-e11.
Crossref
Crossref
Brett M. Morrison, Jennifer L. Lachey, Leigh C. Warsing, Beverlie L. Ting, Abigail E. Pullen, Kathryn W. Underwood, Ravindra Kumar, Dianne Sako, Asya Grinberg, Vicki Wong, Elizabeth Colantuoni, Jasbir S. Seehra & Kathryn R. Wagner. (2009) A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology 217:2, pages 258-268.
Crossref
Crossref
. (2009) Generika in der Psychiatrie; Tiroler Psychologiepreis geht an Schulpsychologen Dr. Hans Henzinger; Ein breites Spektrum für die individuelle Therapie; Konsequente Frühtherapie mit Interferon beta-1b verbessert Langzeitprognose bei multipler Sklerose. Psychopraxis 11:6, pages 40-42.
Crossref
Crossref
. (2008) Adverse Drug Reactions with Donepezil: Analysis of the French Pharmacovigilance Database. Drug Safety 31:10, pages 885-960.
Crossref
Crossref